CollPlant Biotechnologies Ltd. (CLGN)
CollPlant Biotechnologies Market Cap : 5.780M for June 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 191.60M |
| Perspective Therapeutics, Inc. | 408.29M |
| MiMedx Group, Inc. | 532.48M |
| Regentis Biomaterials Ltd. | 8.753M |
| Xylo Technologies Ltd. | 6.495M |
Market Cap Related Metrics
| PS Ratio | 13.17 |
| Price to Book Value | 1.183 |
| Price | 0.401 |
| Earnings Yield | -257.4% |